These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 2222437)

  • 1. Inhibition of myosin light chain phosphorylation in cultured smooth muscle cells by HA1077, a new type of vasodilator.
    Sasaki Y; Sasaki Y
    Biochem Biophys Res Commun; 1990 Sep; 171(3):1182-7. PubMed ID: 2222437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concanavalin A- and fetal-calf-serum-induced rounding and myosin light chain phosphorylation in cultured smooth muscle cells.
    Sasaki Y; Iwata K; Sasaki Y
    J Cell Physiol; 1990 Aug; 144(2):183-9. PubMed ID: 2116423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new type of vasodilator, HA1077, an isoquinoline derivative, inhibits proliferation of bovine vascular smooth muscle cells in culture.
    Shirotani M; Yui Y; Hattori R; Kawai C
    J Pharmacol Exp Ther; 1991 Nov; 259(2):738-44. PubMed ID: 1941621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of HA1077, a protein kinase inhibitor, on myosin phosphorylation and tension in smooth muscle.
    Seto M; Sasaki Y; Hidaka H; Sasaki Y
    Eur J Pharmacol; 1991 Mar; 195(2):267-72. PubMed ID: 1874276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HA1077, a protein kinase inhibitor, inhibits calponin phosphorylation on Ser175 in porcine coronary artery.
    Nagumo H; Seto M; Sakurada K; Walsh MP; Sasaki Y
    Eur J Pharmacol; 1998 Nov; 360(2-3):257-64. PubMed ID: 9851593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective inhibition of myosin phosphorylation and tension of hyperplastic arteries by the kinase inhibitor HA1077.
    Seto M; Shindo K; Ito K; Sasaki Y
    Eur J Pharmacol; 1995 Mar; 276(1-2):27-33. PubMed ID: 7781692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasodilator actions of HA1077 in vitro and in vivo putatively mediated by the inhibition of protein kinase.
    Asano T; Suzuki T; Tsuchiya M; Satoh S; Ikegaki I; Shibuya M; Suzuki Y; Hidaka H
    Br J Pharmacol; 1989 Dec; 98(4):1091-100. PubMed ID: 2611484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydroxyfasudil, an active metabolite of fasudil hydrochloride, relaxes the rabbit basilar artery by disinhibition of myosin light chain phosphatase.
    Nakamura K; Nishimura J; Hirano K; Ibayashi S; Fujishima M; Kanaide H
    J Cereb Blood Flow Metab; 2001 Jul; 21(7):876-85. PubMed ID: 11435800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myosin light chain diphosphorylation is enhanced by growth promotion of cultured smooth muscle cells.
    Seto M; Sakurada K; Kamm KE; Stull JT; Sasaki Y
    Pflugers Arch; 1996 May; 432(1):7-13. PubMed ID: 8662262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HA-1077 suppress both proliferation of vascular smooth muscle cells and c-fos mRNA induction.
    Sase K; Yui Y; Hattori R; Shirotani M; Kawai C; Sasayama S
    Jpn Circ J; 1992 Dec; 56(12):1229-33. PubMed ID: 1479648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Essential role of rho kinase in the Ca2+ sensitization of prostaglandin F(2alpha)-induced contraction of rabbit aortae.
    Ito K; Shimomura E; Iwanaga T; Shiraishi M; Shindo K; Nakamura J; Nagumo H; Seto M; Sasaki Y; Takuwa Y
    J Physiol; 2003 Feb; 546(Pt 3):823-36. PubMed ID: 12563007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myosin light chain phosphorylation in 32P-labeled rabbit aorta stimulated by phorbol 12,13-dibutyrate and phenylephrine.
    Singer HA; Oren JW; Benscoter HA
    J Biol Chem; 1989 Dec; 264(35):21215-22. PubMed ID: 2687275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of Rho-associated kinase blocks agonist-induced Ca2+ sensitization of myosin phosphorylation and force in guinea-pig ileum.
    Swärd K; Dreja K; Susnjar M; Hellstrand P; Hartshorne DJ; Walsh MP
    J Physiol; 2000 Jan; 522 Pt 1(Pt 1):33-49. PubMed ID: 10618150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The molecular mechanism of vasospasm and the attenuation by fasudil].
    Seto M; Takuwa Y; Sasaki Y
    Nihon Yakurigaku Zasshi; 1999 Oct; 114 Suppl 1():66P-70P. PubMed ID: 10629857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamics of myosin light chain phosphorylation at Ser19 and Thr18/Ser19 in smooth muscle cells in culture.
    Sakurada K; Seto M; Sasaki Y
    Am J Physiol; 1998 Jun; 274(6):C1563-72. PubMed ID: 9611121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulatory mechanism by the phosphorylation of 20-kDa light chain of porcine aorta smooth muscle myosin.
    Hasegawa Y; Tanahashi K; Morita F
    J Biochem; 1990 Dec; 108(6):909-13. PubMed ID: 2150966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thin and thick filament regulation of contractility in experimental cerebral vasospasm.
    Kim I; Leinweber BD; Morgalla M; Butler WE; Seto M; Sasaki Y; Peterson JW; Morgan KG
    Neurosurgery; 2000 Feb; 46(2):440-6; discussion 446-7. PubMed ID: 10690734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of HA1077, a novel calciumantagonistic spasmolytic agent on intracerebral arterioles of rats.
    Takayasu M; Dacey RG
    Acta Neurochir (Wien); 1990; 103(1-2):67-70. PubMed ID: 2360470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative determination of α(2B)-adrenoceptor-evoked myosin light chain phosphorylation in vascular smooth muscle cells.
    Björk S; Huhtinen A; Vuorenpää A; Scheinin M
    J Pharmacol Toxicol Methods; 2014; 70(2):152-62. PubMed ID: 25109759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of vanadate on force and myosin light chain phosphorylation in skinned aortic smooth muscle.
    Morimoto S; Sato O; Ogawa Y
    J Biochem; 1999 Jul; 126(1):146-52. PubMed ID: 10393332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.